Skip to main content
VivoSim Labs, INC. logo

VivoSim Labs, INC. — Investor Relations & Filings

Ticker · VIVS ISIN · US68620A2033 US Professional, scientific and technical activities
Open in API
Filings indexed 790 across all filing types
Latest filing 2020-02-13 M&A Activity
Country US United States of America
Listing US VIVS

About VivoSim Labs, INC.

https://organovo.com/

VivoSim Labs, Inc. is a biotechnology services company that develops and utilizes bioprinted, three-dimensional (3D) human tissues designed to emulate human biology and disease. The company provides testing services for drugs and drug candidates, primarily for the pharmaceutical and biotechnology sectors. VivoSim Labs specializes in offering liver and intestinal toxicology insights through its proprietary New Approach Methodologies (NAMs), including its NAMkind™ 3D models. These non-animal testing platforms are used to generate human-relevant safety and toxicology data early in the drug discovery and development process, aiming to provide insights before animal studies or clinical trials.

Recent filings

Filing Released Lang Actions
S-4/A
M&A Activity Classification · 100% confidence The document is a Form S-4/A, which is an amendment to a registration statement filed with the SEC under the Securities Act of 1933. It relates to the registration of securities in connection with a proposed merger between Organovo Holdings, Inc. and Tarveda Therapeutics, Inc. The text includes detailed information about the merger agreement, stockholder meetings, voting proposals, and the issuance of shares as part of the merger transaction. This type of filing is specifically used for merger-related securities registration and disclosures. According to the filing definitions, documents related to merger proposals or takeover bids are classified under 'M&A Activity' (Code: TAR). The document is not an annual report, earnings release, proxy solicitation, or other categories but clearly pertains to merger activity and registration of securities in connection with that merger.
2020-02-13 English
SC 13G
Major Shareholding Notification
2020-02-12 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-02-12 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-02-12 English
Regulatory Filings 2020
Regulatory Filings Classification · 90% confidence The provided document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, form names, fiscal period dates, or document titles that can be used to identify the filing type. The text is not interpretable as a financial report, announcement, or any specific filing category. Given the lack of meaningful content and inability to classify it into any specific category, the appropriate classification is the fallback category: Regulatory Filings (RNS).
2020-02-11 English
10-Q
Interim / Quarterly Report Q3 2020
2020-02-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.